Advisory Services Network, LLC Novo Cure LTD Transaction History

Advisory Services Network, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $9,070 - $12,860	815 New	815 $12,000
Q1 2023 May 17, 2023	SELL	$56.44 - $118.81 $3,668 - $7,722	-65 Reduced 2.18%	2,922 $175,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $1,427 - $1,880	-21 Reduced 0.7%	2,987 $227,000
Q2 2022 Aug 02, 2022	SELL	$56.6 - $89.9 $8,999 - $14,294	-159 Reduced 5.02%	3,008 $209,000
Q1 2022 May 23, 2022	SELL	$60.15 - $84.52 $66,646 - $93,648	-1,108 Reduced 25.92%	3,167 $262,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $218,332 - $354,746	-2,908 Reduced 40.48%	4,275 $321,000
Q3 2021 Nov 05, 2021	BUY	$116.17 - $194.55 $12,778 - $21,400	110 Added 1.56%	7,183 $834,000
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $172,519 - $298,442	-1,323 Reduced 15.76%	7,073 $1.57 Million
Q1 2021 May 24, 2021	SELL	$124.11 - $190.17 $369,351 - $565,945	-2,976 Reduced 26.17%	8,396 $1.11 Million
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $1.15 Million - $1.79 Million	10,292 Added 952.96%	11,372 $1.97 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $62,694 - $120,214	1,080 New	1,080 $121,000
Q2 2020 Aug 10, 2020	SELL	$57.2 - $74.41 $51,766 - $67,341	-905 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $34,515 - $57,928	605 Added 201.67%	905 $61,000
Q4 2019 Feb 04, 2020	BUY	$68.3 - $93.8 $20,490 - $28,140	300 New	300 $25,000
Q1 2019 May 20, 2019	SELL	$31.96 - $56.12 $830 - $1,459	-26 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$28.72 - $52.63 $746 - $1,368	26 New	26 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.